soul trial oral semaglutide cardiovascular outcomes results 2024 2025 nejm Editorial Fellow Harleen Marwah, MD, summarizes the trial. Read the full at NEJM.org (link in bio). , , #ACC25 #Cardiology #ClinicalTrials #NEJM The SOUL Study - by
Description
For now, the Wegovy pill is the main weight-loss tablet licensed in the UK
FIGHT and LIVE Trials: Liraglutide showed neutral effects in heart failure with reduced ejection fraction (HFrEF), highlighting the need for further research in this phenotype [59,60]
The second subset's samples ( n = 5) were preserved at 80 C for biochemical determinations after being frozen in liquid nitrogen
Were not trying to push everyone toward one option or the other
